This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Fumie Yamaguchi: Pioneer in Pharmaceutical Innovations
Introduction: Fumie Yamaguchi, a renowned inventor hailing from Fujisawa, JP, is celebrated for his groundbreaking work in the field of pharmaceuticals.
Latest Patents: With an impressive portfolio of 1 patent, Fumie Yamaguchi's innovative creation, the Heterocyclic NMDA antagonists compound, shows promise as a prophylactic or therapeutic agent for various conditions like depression, bipolar disorder, migraine, and more.
Career Highlights: Fumie Yamaguchi is a key figure at Takeda Pharmaceutical Company Limited, a leading entity in the pharmaceutical industry known for its cutting-edge research and development.
Collaborations: Fumie Yamaguchi has collaborated with esteemed colleagues such as Shuhei Ikeda and Makoto Kamata, pooling their expertise to push the boundaries of pharmaceutical innovations further.
Conclusion: Fumie Yamaguchi's contributions to the field of pharmaceutical innovations stand as a testament to his ingenuity and dedication, paving the way for advancements in healthcare and treatment options globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile